If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Renewals

7 Feb 2006 07:00

e2v technologies PLC07 February 2006 7 February 2006 e2v secures two contract renewals worth £21m e2v technologies announces it has won two contract renewals worth a total of£21m. Both contracts are for existing OEM customers and are for products within e2v'selectronic tubes product group for use within radiotherapy cancer treatmentsystems. These products generate and deliver the exceptional levels of microwave powerrequired to drive the linear accelerator within radiotherapy systems, whichconvert the microwave power to X-rays used both in the imaging and radiationtreatment of tumours. e2v has been supporting this important application for inexcess of 30 years and works closely with OEM customers to improve theperformance and reliability of their systems. The largest of the contracts, worth £17m, and with delivery over a 3 yearperiod, is to supply Elekta, headquartered in Sweden with manufacturingfacilities in the UK and China. The second contract, worth $7m (£4m), is with TomoTherapy(R) Inc, based inWisconsin, USA. Delivery is scheduled over a 12 month period. Keith Attwood, Chief Executive of e2v said: "The renewal of these two contracts reinforces our position as a strategicsupplier into the radiotherapy equipment market and is entirely consistent withguidance given in our Interim Report and Accounts issued in December 2005." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Charlotte Stone/Keith Brookbank NOTES FOR EDITORS e2v technologies plc e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. It is listed on the London Stock Exchange(e2v.l). e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into three core areas: •Medical & Science : Sensor technology includes Dental X-ray, Mammography, life science applications and X-ray microscopy. Electronic Tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. •Aerospace & Defence : Sensor technology includes military surveillance, targeting and guidance; space-based imaging and astronomy and radar & electronic warfare. Electronic tubes provide the enabling technology behind radars, electronic countermeasures (ECM), electronic warfare and satellite communications. •Commercial & Industrial : Sensor technology includes marine radars, industrial safety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters. Electronic tubes provide enabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. e2v has 1,300 employees worldwide with offices in UK, USA, Germany, France,Canada and a presence in China through the China Britain Business Council, aswell as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Dec 20162:41 pmRNSForm 8.3 - E2V Technologies PLC
15th Dec 20161:19 pmRNSForm 8.3 - e2v Technologies plc
15th Dec 20169:00 amRNSForm 8.5 (EPT/RI)
14th Dec 20165:22 pmRNSForm 8.3 - e2e technologies PLC
14th Dec 20165:15 pmRNSForm 8.3 - E2V TECHNOLOGIES PLC
14th Dec 20163:07 pmRNSHolding(s) in Company
14th Dec 20161:19 pmPRNForm 8.3 - e2v technologies plc
14th Dec 20169:45 amRNSForm 8.3 - E2V Technologies
14th Dec 20168:37 amBUSForm 8.3 - E2V Technologies PLC
13th Dec 20163:27 pmRNSForm 8.3 - E2V Technologies Plc
13th Dec 20163:20 pmRNSRule 2.9 Announcement
13th Dec 20163:20 pmRNSForm 8.3 - e2v Technologies Plc
13th Dec 20162:52 pmRNSForm 8.3 - e2v technologies plc
13th Dec 20162:15 pmRNSForm 8.3 - e2v Technologies Plc
13th Dec 20162:02 pmRNSForm 8.3 - [e2v Technologies plc]
13th Dec 201611:50 amRNSForm 8.3 - e2v Technologies plc
13th Dec 201611:16 amRNSForm 8.3 - E2V Technologies
13th Dec 201611:02 amRNSForm 8.3 - E2V Technologies Plc
13th Dec 20169:04 amBUSForm 8.3 - E2V Technologies PLC
13th Dec 20168:52 amRNSForm 8.5 (EPT/RI)
12th Dec 20163:44 pmRNSForm 8.3 - e2v Technologies Plc
12th Dec 20163:07 pmRNSForm 8.3 - E2V Technologies Plc
12th Dec 201610:39 amPRNRule 8.3 - E2V Technologies PLC
12th Dec 20169:49 amRNSForm 8.3 - e2v technologies plc
12th Dec 20167:00 amRNSRecommended Cash Acquisition
8th Dec 20169:08 amRNSTotal Voting Rights
28th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20165:03 pmRNSHolding(s) in Company
10th Nov 20165:29 pmRNSHolding(s) in Company
8th Nov 201612:06 pmRNSHolding(s) in Company
8th Nov 20169:21 amRNSTotal Voting Rights
7th Nov 201611:20 amRNSPDMR Share Purchase
7th Nov 201610:37 amRNSPDMR Share Purchase
7th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20163:54 pmRNSDirectorate Change
14th Oct 20169:15 amRNSBlock listing return
11th Oct 20162:48 pmRNSDirectorate Change
3rd Oct 20169:27 amRNSTotal Voting Rights
21st Sep 20163:12 pmRNSHolding(s) in Company
5th Sep 20163:09 pmRNSReplacement - Total Voting Rights
5th Sep 20161:30 pmRNSTotal Voting Rights
30th Aug 201612:29 pmRNSHolding(s) in Company
25th Aug 201610:11 amRNSInvestor site visit and presentation
8th Aug 20161:05 pmRNSTotal Voting Rights
19th Jul 20161:11 pmRNSHolding(s) in Company
14th Jul 20168:48 amRNSResult of AGM
13th Jul 20167:00 amRNSDirectorate Change
13th Jul 20167:00 amRNSAGM Update
11th Jul 20169:03 amRNSDirectorate Change
6th Jul 201612:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.